FCMI

Foresite Capital Management IV Portfolio holdings

AUM $124M
This Quarter Return
+20.24%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$921M
AUM Growth
+$921M
Cap. Flow
+$406M
Cap. Flow %
44.07%
Top 10 Hldgs %
97.69%
Holding
17
New
2
Increased
2
Reduced
2
Closed
4

Top Buys

1
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$385M
2
OLMA icon
Olema Pharmaceuticals
OLMA
$39.3M
3
KURA icon
Kura Oncology
KURA
$16.3M
4
ACRS icon
Aclaris Therapeutics
ACRS
$5.22M

Top Sells

1
MYOK
MyoKardia, Inc. Common Stock
MYOK
$17.2M
2
ABUS icon
Arbutus Biopharma
ABUS
$10.4M
3
VYGR icon
Voyager Therapeutics
VYGR
$5.51M
4
CYTK icon
Cytokinetics
CYTK
$4.91M
5
PANA.U
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$1.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$385M 41.79% +9,671,643 New +$385M
KROS icon
2
Keros Therapeutics
KROS
$618M
$99.7M 10.82% 1,412,705 – –
RLAY icon
3
Relay Therapeutics
RLAY
$619M
$88.9M 9.66% 2,139,380 – –
ALXO icon
4
ALX Oncology
ALXO
$62.7M
$83.9M 9.12% 973,514 – –
NRIX icon
5
Nurix Therapeutics
NRIX
$714M
$77.2M 8.39% 2,347,804 -210 -0% -$6.91K
KURA icon
6
Kura Oncology
KURA
$686M
$59M 6.41% 1,807,982 +500,000 +38% +$16.3M
OLMA icon
7
Olema Pharmaceuticals
OLMA
$375M
$39.3M 4.27% +818,030 New +$39.3M
CYTK icon
8
Cytokinetics
CYTK
$4.23B
$29.8M 3.24% 1,435,992 -236,300 -14% -$4.91M
GBIO icon
9
Generation Bio
GBIO
$40.4M
$24.3M 2.64% 857,939 – –
PCVX icon
10
Vaxcyte
PCVX
$4B
$12.4M 1.34% 465,821 – –
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
$10.3M 1.11% 1,787,094 – –
ACRS icon
12
Aclaris Therapeutics
ACRS
$209M
$6.16M 0.67% 951,384 +806,510 +557% +$5.22M
PNT
13
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$4.87M 0.53% 350,000 – –
ABUS icon
14
Arbutus Biopharma
ABUS
$711M
– – -3,332,616 Closed -$10.4M
VYGR icon
15
Voyager Therapeutics
VYGR
$186M
– – -516,751 Closed -$5.51M
PANA.U
16
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
– – -150,000 Closed -$1.8M
MYOK
17
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– – -126,492 Closed -$17.2M